Latest Breaking News On - Myra vision inc - Page 1 : vimarsana.com

MYRA VISION S CALIBREYE™ TITRATABLE GLAUCOMA THERAPY™ SURGICAL SYSTEM SHOWCASED AT OPHTHALMOLOGY CONFERENCES, RECEIVING BEST PAPER AWARD AND RECOGNITION OF FUTURE PROMISE IN GLAUCOMA CARE

/PRNewswire/ Myra Vision, a Shifamed portfolio company, announced today its Calibreye™ Titratable Glaucoma Therapy™ (TGT) Surgical System, a next-generation.

United statesUnited kingdomAbu dhabiKeith bartonKatie arnoldStephena obstbaumMyra calibreyeUniversity of utahEuropean glaucoma societyLeon herndon duke eye centerAssociation for researchInstitute of ophthalmologyMyra vision incJohn moran eye centerAmerican society of cataractFounder co

Myra Vision, Inc : MYRA VISION ANNOUNCES SUCCESSFUL FIRST-IN-HUMAN USE OF ITS CALIBREYE SYSTEM, A NEXT GENERATION AQUEOUS SHUNT THERAPY FOR PATIENTS WITH MODERATE TO SEVERE GLAUCOMA

Myra Vision, Inc : MYRA VISION ANNOUNCES SUCCESSFUL FIRST-IN-HUMAN USE OF ITS CALIBREYE SYSTEM, A NEXT GENERATION AQUEOUS SHUNT THERAPY FOR PATIENTS WITH MODERATE TO SEVERE GLAUCOMA
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Baden wübergRohit varmaIqbal ikek ahmedAmr salahiehKatie arnoldRobert changAlans crandall centerJohna moran eye centerMyra vision incOphthalmology futures european forumUniversity of torontoSouthern california eye institute in los angelesCalibreye systemFounding directorSouthern california eye instituteLos angeles

MYRA VISION ANNOUNCES SUCCESSFUL FIRST-IN-HUMAN USE OF ITS CALIBREYE™ SYSTEM, A NEXT GENERATION AQUEOUS SHUNT THERAPY FOR PATIENTS WITH MODERATE TO SEVERE GLAUCOMA

MYRA VISION ANNOUNCES SUCCESSFUL FIRST-IN-HUMAN USE OF ITS CALIBREYE™ SYSTEM, A NEXT GENERATION AQUEOUS SHUNT THERAPY FOR PATIENTS WITH MODERATE TO SEVERE GLAUCOMA
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKatie arnoldLos angelesJohna moranRobert changIqbal ikek ahmedRohit varmaAmr salahiehOphthalmology futures european forumAlans crandall centerSouthern california eye instituteMyra vision incCalibreye systemFounding directorGlaucoma innovationAdvanced anterior

Myra Vision, A Shifamed Portfolio Company, Closes $17M In Series A Financings

Myra Vision, A Shifamed Portfolio Company, Closes $17M In Series A Financings Company to accelerate development of the first-of-its-kind treatment for patients with moderate to severe glaucoma News provided by Share this article Share this article CAMPBELL, Calif., June 1, 2021 /PRNewswire/ Myra Vision, a Shifamed portfolio company, announced today the closing of its $17M Series A financings, which will be used to advance product development, scale infrastructure, and expand their team in order to support the development of the first of its kind glaucoma treatment device. The financings were led by The Capital Partnership (TCP), with participation from Cormorant Asset Management and Shifamed angel investors. In conjunction with the financing, the company has changed its name to Myra Vision, Inc. from Myra Medical, Inc.

Amr salahiehKatie arnoldRobert changCasey gordonMyra vision incCapital partnershipMyra medical incMyra visionCormorant asset managementMyra medicalPrivate investmentsNew ab interno gelatin stentRefractory glaucomaகேடீ அர்னால்ட்ராபர்ட் சாங்வழக்கு கோர்டந்